Index
1 Histone Deacetylase (HDAC) Inhibitors Market Overview
1.1 Product Overview and Scope of Histone Deacetylase (HDAC) Inhibitors
1.2 Histone Deacetylase (HDAC) Inhibitors Segment by Type
1.2.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value Comparison by Type (2024-2030)
1.2.2 Fatty Acid
1.2.3 Hydroxamate
1.2.4 Cyclic Peptide
1.2.5 Benzamide
1.3 Histone Deacetylase (HDAC) Inhibitors Segment by Application
1.3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Value by Application: (2024-2030)
1.3.2 Treatment of Malignant Tumors
1.3.3 Chronic Disease Treatment
1.3.4 Others
1.4 Global Histone Deacetylase (HDAC) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue 2019-2030
1.4.2 Global Histone Deacetylase (HDAC) Inhibitors Sales 2019-2030
1.4.3 Global Histone Deacetylase (HDAC) Inhibitors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Histone Deacetylase (HDAC) Inhibitors Market Competition by Manufacturers
2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Histone Deacetylase (HDAC) Inhibitors Average Price by Manufacturers (2019-2024)
2.4 Global Histone Deacetylase (HDAC) Inhibitors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Histone Deacetylase (HDAC) Inhibitors, Product Type & Application
2.7 Histone Deacetylase (HDAC) Inhibitors Market Competitive Situation and Trends
2.7.1 Histone Deacetylase (HDAC) Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Histone Deacetylase (HDAC) Inhibitors Players Market Share by Revenue
2.7.3 Global Histone Deacetylase (HDAC) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Histone Deacetylase (HDAC) Inhibitors Retrospective Market Scenario by Region
3.1 Global Histone Deacetylase (HDAC) Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2019-2030
3.2.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2019-2024
3.2.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Region: 2025-2030
3.3 Global Histone Deacetylase (HDAC) Inhibitors Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019-2030
3.3.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2019-2024
3.3.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Region: 2025-2030
3.4 North America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.4.1 North America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.4.3 North America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.5.3 Europe Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.6.3 Asia Pacific Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.7.3 Latin America Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Histone Deacetylase (HDAC) Inhibitors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2019-2030)
4.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2019-2024)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Type (2025-2030)
4.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Type (2019-2030)
4.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2019-2030)
4.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2019-2024)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Type (2025-2030)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Type (2019-2030)
4.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2019-2030)
5.1.1 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2019-2024)
5.1.2 Global Histone Deacetylase (HDAC) Inhibitors Sales by Application (2025-2030)
5.1.3 Global Histone Deacetylase (HDAC) Inhibitors Sales Market Share by Application (2019-2030)
5.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2019-2030)
5.2.1 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2019-2024)
5.2.2 Global Histone Deacetylase (HDAC) Inhibitors Revenue by Application (2025-2030)
5.2.3 Global Histone Deacetylase (HDAC) Inhibitors Revenue Market Share by Application (2019-2030)
5.3 Global Histone Deacetylase (HDAC) Inhibitors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 4SC
6.1.1 4SC Corporation Information
6.1.2 4SC Description and Business Overview
6.1.3 4SC Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 4SC Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.1.5 4SC Recent Developments/Updates
6.2 Acetylon Pharmaceuticals
6.2.1 Acetylon Pharmaceuticals Corporation Information
6.2.2 Acetylon Pharmaceuticals Description and Business Overview
6.2.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.2.5 Acetylon Pharmaceuticals Recent Developments/Updates
6.3 Celleron Therapeutics
6.3.1 Celleron Therapeutics Corporation Information
6.3.2 Celleron Therapeutics Description and Business Overview
6.3.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.3.5 Celleron Therapeutics Recent Developments/Updates
6.4 Chipscreen Biosciences
6.4.1 Chipscreen Biosciences Corporation Information
6.4.2 Chipscreen Biosciences Description and Business Overview
6.4.3 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chipscreen Biosciences Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.4.5 Chipscreen Biosciences Recent Developments/Updates
6.5 Chroma Therapeutics
6.5.1 Chroma Therapeutics Corporation Information
6.5.2 Chroma Therapeutics Description and Business Overview
6.5.3 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chroma Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.5.5 Chroma Therapeutics Recent Developments/Updates
6.6 CrystalGenomics
6.6.1 CrystalGenomics Corporation Information
6.6.2 CrystalGenomics Description and Business Overview
6.6.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.6.5 CrystalGenomics Recent Developments/Updates
6.7 Curis
6.6.1 Curis Corporation Information
6.6.2 Curis Description and Business Overview
6.6.3 Curis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Curis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.7.5 Curis Recent Developments/Updates
6.8 MEI Pharma
6.8.1 MEI Pharma Corporation Information
6.8.2 MEI Pharma Description and Business Overview
6.8.3 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MEI Pharma Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.8.5 MEI Pharma Recent Developments/Updates
6.9 Mirati Therapeutics
6.9.1 Mirati Therapeutics Corporation Information
6.9.2 Mirati Therapeutics Description and Business Overview
6.9.3 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mirati Therapeutics Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.9.5 Mirati Therapeutics Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Onxeo
6.11.1 Onxeo Corporation Information
6.11.2 Onxeo Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.11.3 Onxeo Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Onxeo Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.11.5 Onxeo Recent Developments/Updates
6.12 Repligen
6.12.1 Repligen Corporation Information
6.12.2 Repligen Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.12.3 Repligen Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Repligen Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.12.5 Repligen Recent Developments/Updates
6.13 TetraLogic
6.13.1 TetraLogic Corporation Information
6.13.2 TetraLogic Histone Deacetylase (HDAC) Inhibitors Description and Business Overview
6.13.3 TetraLogic Histone Deacetylase (HDAC) Inhibitors Sales, Revenue and Gross Margin (2019-2024)
6.13.4 TetraLogic Histone Deacetylase (HDAC) Inhibitors Product Portfolio
6.13.5 TetraLogic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Histone Deacetylase (HDAC) Inhibitors Industry Chain Analysis
7.2 Histone Deacetylase (HDAC) Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Histone Deacetylase (HDAC) Inhibitors Production Mode & Process
7.4 Histone Deacetylase (HDAC) Inhibitors Sales and Marketing
7.4.1 Histone Deacetylase (HDAC) Inhibitors Sales Channels
7.4.2 Histone Deacetylase (HDAC) Inhibitors Distributors
7.5 Histone Deacetylase (HDAC) Inhibitors Customers
8 Histone Deacetylase (HDAC) Inhibitors Market Dynamics
8.1 Histone Deacetylase (HDAC) Inhibitors Industry Trends
8.2 Histone Deacetylase (HDAC) Inhibitors Market Drivers
8.3 Histone Deacetylase (HDAC) Inhibitors Market Challenges
8.4 Histone Deacetylase (HDAC) Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer